The most characteristic features of diphtheria affecting the upper respiratory tract are:
- membranous pharyngitis with fever
- enlarged lymph nodes
- swelling of soft tissue
This swelling may then cause respiratory obstruction.
Go to the Public Health England website to view:
For all infection prevention and control guidance visit the A-Z pathogens section of the National Infection and Prevention Control Manual.
Data and surveillance
Diphtheria is a notifiable disease and toxic Corynebacterium diphtheriae and Corynebacterium ulcerans are notifiable organisms under The Public Health etc. (Scotland) Act 2008.
In Scotland, the classical respiratory disease is now very rare and skin infections aren't reported very often.
Report cases of infection with our surveillance forms for toxin-producing Corynebacterium.
In the early 1940s vaccination against diphtheria was introduced. Diphtheria vaccine is still included in the UK childhood immunisation schedule, with routine primary vaccination recommended at eight, twelve and sixteen weeks, followed by a booster dose from age three years four months and a further booster from 13 to 18 years.
View our latest diphtheria vaccination uptake statistics.